Mar 1 |
Celldex prices $400.4M stock offering
|
Mar 1 |
Celldex Therapeutics Announces Pricing of Upsized $400 Million Public Offering of Common Stock
|
Feb 29 |
Celldex (CLDX) Upgraded to Buy: What Does It Mean for the Stock?
|
Feb 29 |
Wall Street Analysts Predict a 26.53% Upside in Celldex (CLDX): Here's What You Should Know
|
Feb 28 |
Celldex Therapeutics announces proposed public offering of shares
|
Feb 27 |
Celldex Therapeutics Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags
|
Feb 26 |
Celldex Stock Hits 11-Month High, Up 19%, On A Promising New Hives Treatment
|
Feb 26 |
Celldex Therapeutics: Q4 Earnings Insights
|
Feb 26 |
Celldex Therapeutics (CLDX) Reports Q4 Loss, Tops Revenue Estimates
|
Feb 26 |
Celldex Therapeutics Inc (CLDX) Reports Q4 and Full Year 2023 Financial Results
|